These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 39304235)
101. Components of Existing National Surgical Site Infection Surveillance Programs Based on a Case Series of Low- and Middle-Income Countries: Building Blocks for Success and Opportunities for Improvement. Forrester JD; Bekele A; Stefan AM; Tshokey T; Berndtson AE; Beyene RT; Chou J; Sawyer RG; Valenzuela JY; Rickard J Surg Infect (Larchmt); 2023 Mar; 24(2):112-118. PubMed ID: 36629853 [No Abstract] [Full Text] [Related]
102. Qualitative assessment of the national initiative to implement antimicrobial stewardship centres in French administrative regions. Conlin M; Leroy AG; Asquier-Khati A; Boutoille D; Birgand G Antimicrob Resist Infect Control; 2023 Apr; 12(1):41. PubMed ID: 37098636 [TBL] [Abstract][Full Text] [Related]
103. The Global call for action on infection prevention and control. Avortri GS; Nabyonga-Orem J Int J Health Care Qual Assur; 2019 Jul; 32(6):927-940. PubMed ID: 31282256 [TBL] [Abstract][Full Text] [Related]
104. Evaluating national infection prevention and control minimum requirements: evidence from global cross-sectional surveys, 2017-22. Tartari E; Tomczyk S; Twyman A; Rehse APC; Gomaa M; Talaat M; Shah AS; Sobel H; Toledo JP; Allegranzi B Lancet Glob Health; 2024 Oct; 12(10):e1620-e1628. PubMed ID: 39304235 [TBL] [Abstract][Full Text] [Related]
105. Baseline evaluation of the World Health Organization (WHO) infection prevention and control (IPC) core components in Pacific Island Countries and Territories (PICTs). Leong M; Picton R; Wratten M; Mahe A; Zimmerman PA Antimicrob Resist Infect Control; 2024 Sep; 13(1):108. PubMed ID: 39334478 [TBL] [Abstract][Full Text] [Related]
106. Implementation of the infection prevention and control core components at the national level: a global situational analysis. Tartari E; Tomczyk S; Pires D; Zayed B; Coutinho Rehse AP; Kariyo P; Stempliuk V; Zingg W; Pittet D; Allegranzi B J Hosp Infect; 2021 Feb; 108():94-103. PubMed ID: 33271215 [TBL] [Abstract][Full Text] [Related]
107. Infection prevention and control (IPC) implementation in low-resource settings: a qualitative analysis. Tomczyk S; Storr J; Kilpatrick C; Allegranzi B Antimicrob Resist Infect Control; 2021 Jul; 10(1):113. PubMed ID: 34332622 [TBL] [Abstract][Full Text] [Related]
108. Global incidence in hospital-associated infections resistant to antibiotics: An analysis of point prevalence surveys from 99 countries. Balasubramanian R; Van Boeckel TP; Carmeli Y; Cosgrove S; Laxminarayan R PLoS Med; 2023 Jun; 20(6):e1004178. PubMed ID: 37310933 [TBL] [Abstract][Full Text] [Related]
109. Effectiveness of national and subnational interventions for prevention and control of health-care-associated infections in acute hospitals in high-income and upper-middle-income counties: a systematic review update. Price L; Gozdzielewska L; Hendry K; McFarland A; Reilly J Lancet Infect Dis; 2023 Sep; 23(9):e347-e360. PubMed ID: 37023784 [TBL] [Abstract][Full Text] [Related]
110. First nationwide survey of infection prevention and control among healthcare facilities in Japan: impact of the national regulatory system. Nomoto H; Saito H; Ishikane M; Gu Y; Ohmagari N; Pittet D; Kunishima H; Allegranzi B; Yoshida M Antimicrob Resist Infect Control; 2022 Nov; 11(1):135. PubMed ID: 36352429 [TBL] [Abstract][Full Text] [Related]
111. Infection prevention and control in tertiary care hospitals of Bangladesh: results from WHO infection prevention and control assessment framework (IPCAF). Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Haque T; Mah-E-Muneer S; Rahman A; Abdullah SAHM; Islam MS; Styczynski AR; Kaydos-Daniels SC Antimicrob Resist Infect Control; 2022 Oct; 11(1):125. PubMed ID: 36203207 [TBL] [Abstract][Full Text] [Related]
112. Update Alert 11: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers. Chou R; Dana T; Buckley DI; Selph S; Fu R; Totten AM Ann Intern Med; 2022 Aug; 175(8):W83-W84. PubMed ID: 35816711 [No Abstract] [Full Text] [Related]
113. Status of hospital infection prevention practices in Thailand in the era of COVID-19: Results from a national survey. Thaprawat P; Greene MT; Saint S; Kasatpibal N; Fowler KE; Apisarnthanarak A Am J Infect Control; 2022 Sep; 50(9):975-980. PubMed ID: 35718059 [TBL] [Abstract][Full Text] [Related]
114. Implementation of infection prevention and control practices in an upcoming COVID-19 hospital in India: An opportunity not missed. Das A; Garg R; Kumar ES; Singh D; Ojha B; Kharchandy HL; Pathak BK; Srikrishnan P; Singh R; Joshua I; Nandekar S; J V; Reghu R; Pedapanga N; Banerjee T; Yadav KK PLoS One; 2022; 17(5):e0268071. PubMed ID: 35604919 [TBL] [Abstract][Full Text] [Related]
115. The first WHO global survey on infection prevention and control in health-care facilities. Tomczyk S; Twyman A; de Kraker MEA; Coutinho Rehse AP; Tartari E; Toledo JP; Cassini A; Pittet D; Allegranzi B Lancet Infect Dis; 2022 Jun; 22(6):845-856. PubMed ID: 35202599 [TBL] [Abstract][Full Text] [Related]